Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer

Maadi, Hamid, Moshtaghian, Abdolvahab, Taha, Masoumeh Fakhr, Mowla, Seyed Javad, Kazeroonian, Asiye, Haass, Nikolas K. and Javeri, Arash (2016) Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer. International Journal of Biochemistry and Cell Biology, 81 A: 121-132. doi:10.1016/j.biocel.2016.11.004


Author Maadi, Hamid
Moshtaghian, Abdolvahab
Taha, Masoumeh Fakhr
Mowla, Seyed Javad
Kazeroonian, Asiye
Haass, Nikolas K.
Javeri, Arash
Title Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer
Journal name International Journal of Biochemistry and Cell Biology   Check publisher's open access policy
ISSN 1878-5875
1357-2725
Publication date 2016-12-01
Sub-type Article (original research)
DOI 10.1016/j.biocel.2016.11.004
Open Access Status Not yet assessed
Volume 81
Issue A
Start page 121
End page 132
Total pages 12
Place of publication Kidlington, Oxford, United Kingdom
Publisher Pergamon Press
Language eng
Abstract The miR-302 family is one of the main groups of microRNAs, which are highly expressed in embryonic stem cells (ESCs). Previous reports have indicated that miR-302 can reduce the proliferation rate of some cancer cells while compromising on their oncogenic potential at the same time without having the same effect on normal somatic cells. In this study we aimed to further investigate the role of the miR-302 cluster in multiple cancer signaling pathways using A-375 melanoma and HT-29 colorectal cancer cells. Our results indicate that the miR-302 cluster has the potential to modulate oncogenic properties of cancer cells through inhibition of proliferation, angiogenesis and invasion, and through reversal of the epithelial-to-mesenchymal transition (EMT) in these cells. We showed for the first time that overexpression of miR-302 cluster sensitized A-375 and HT-29 cells to hypoxia and also to the selective BRAF inhibitor vemurafenib. MiR-302 is a pleiotropically acting miRNA family which may have significant implications in controlling cancer progression and invasion. It acts through a reprogramming process, which has a global effect on a multitude of cellular pathways and events. We propose that reprogramming of cancer cells by epigenetic factors, especially miRNAs might provide an efficient tool for controlling cancer and especially for those with more invasive nature.
Keyword Cancer
Colon
MiRNA
Reprogramming
Skin
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
UQ Diamantina Institute Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 1 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 06 Dec 2016, 10:41:20 EST by System User on behalf of Learning and Research Services (UQ Library)